BrainTech Alliance: How data and AI are transforming neuro-innovation?
After Palo Alto, London and San Francisco, the BrainTech Alliance will convene for the first time in Paris, on September 15, at the Paris Brain Institute.
Co-founded by venture capital firms Newfund Heka, Ground Effect and Satori Neuro, the BrainTech Alliance is the premier meeting point between fundamental research, cutting-edge entrepreneurship and strategic investment.
This 4th edition will explore a central challenge for the NeuroTech ecosystem: how data and AI are transforming neuro-innovation.
Preliminary Program
3:00 PM – 3:10 PM: Introduction Pr Stéphanie Debette, Paris Brain Institute; François Véron, BrainTech Alliance, Newfund Heka
3:10 PM – 3:30 PM: Keynote Ira Hebold Haraldsen, AI-Mind Project Coordinator, BrainSymph Chair
3:30 PM – 3:45 PM: Session 1: Data Collection in Neuroscience How can we rethink data collection to make it a real driver of innovation in brain diseases?
Sylvie Bothorel, Chief Data Officer, Paris Brain Institute
Ira Hebold Haraldsen, AI-Mind Project Coordinator, BrainSymph Chair
Thomas Nedelec, Research Scientist, Paris Brain Institute
Facilitator: Géraldine Farjot, Director Innovation, Paris Brain Institute
4:00 PM – 4:45 PM: Session 2: From Biomarker to Product From data collection to clinical use: how to identify biomarkers and deploy them in clinical practice?
Pr Franck Bielle, Neuropathology, Paris Brain Institute
Franck Augé, Director R&D Search & Evaluation, AI and Digital Technologies, Servier
Paul Herent, CEO of Radium
Facilitator: François Veron, Managing Partner, Newfund
4:45 PM – 5:30 PM: Session 3: From Innovation to Market The challenges of scaling up in neuroscience
Pr Jean-Christophe Corvol, Neurologist, Parkinson's, Coordinator NS-PARK, Remote Monitoring
Thomas Trailov, VP Partnerships & Strategy, Healthcare, Air Liquide
Amy Kruse, General Partner, Satori Neuro
Facilitator: John Propst, Managing Partner, Ground Effect Ventures
5:30 PM – 5:45 PM: Conclusion
5:45 PM – 8:00 PM: Networking Cocktail
About the speakers :
Prof. Stéphanie Debette — Executive Director, Paris Brain Institute Neurologist and epidemiologist at Sorbonne University/AP-HP, she has led the Paris Brain Institute since 2025. Her research focuses on the genetics of stroke, brain aging markers, and cognitive decline. She received the Inserm Grand Prix and was inducted into the French Academy of Sciences in 2024.
Ira Hebold Haraldsen — AI-Mind Project Coordinator / BrainSymph Chair MD-PhD in neurology and psychiatry, she leads the Cognitive Health Research group at Oslo University Hospital. She coordinates AI-Mind, a €14M Horizon 2020 project across 8 European countries developing AI tools for brain connectivity screening and dementia risk estimation.
Sylvie Bothorel — Chief Data Officer, Paris Brain Institute She co-leads the AI & Data Science Center at the Paris Brain Institute, a 90-person team focused on advanced brain imaging analysis and precision medicine for neurological diseases.
Thomas Nedelec — Research Scientist, Paris Brain Institute PhD in Applied Mathematics (Paris-Saclay) and graduate of École Polytechnique, he researches the epidemiology of neurological disorders and early disease detection using large real-world health databases across international consortia.
Prof. Franck Bielle — Neuropathology, Paris Brain Institute Professor at Sorbonne University and practitioner at Pitié-Salpêtrière, he leads the Genetics and Development of Brain Tumors team at the Paris Brain Institute. His research focuses on the molecular classification of brain tumors and resistance to treatment, with over 270 publications.
Franck Augé — Director R&D Search & Evaluation, AI & Digital Technologies, Servier At Servier since 2024, he oversees AI and computational science for R&D. He previously spent over 20 years at Sanofi leading omics data science and biomarker identification.
Paul Hérent — CEO & Co-founder, Raidium Radiologist and entrepreneur, he co-founded Raidium in 2022 to build the first AI foundation model for radiology. The company launched an AI-native PACS at RSNA 2025, powered by a multimodal model trained on over one billion images.
Prof. Jean-Christophe Corvol — Neurologist, Paris Brain Institute / NS-PARK Coordinator Professor of Neurology at Pitié-Salpêtrière, he co-chairs NS-PARK, the French clinical research network on Parkinson's disease, and leads the Molecular Pathophysiology of Parkinson's Disease team at the Paris Brain Institute. He has published over 336 peer-reviewed articles (H-index 74).
Thomas Trailov — VP Partnerships & Strategy, Healthcare, Air Liquide VP of Partnerships & Strategy at Air Liquide Healthcare, the health division of the Air Liquide Group, a world leader in medical gases and home healthcare services. He drives strategic partnerships to advance value-based care.
Please note that photos will be taken during the event. By attending, you consent to potentially being photographed. If you do not wish to appear in any photos, please let us know before the event.